Acceptance and Commitment Therapy for Religious OCD

March 17, 2026 updated by: David Johnson, University of Alabama at Birmingham

Efficacy of Acceptance and Commitment Therapy on Religiously Oriented Obsessive-Compulsive Disorder

The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35233
        • Recruiting
        • University of Alabama at Birmingham
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years old
  • Meet cutoff scores for scrupulosity

Exclusion Criteria:

  • Presence of psychotic symptoms within six months of screening
  • Current suicidal/homicidal plan/intent and/or a suicide/homicide attempt within 6 months of screening
  • Non-suicidal self-injury within 6 months of screening
  • Narcotics use within 3 months of screening
  • Purging/restricting behavior within 3 months of screening.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acceptance and Commitment Therapy
Participants will receive twelve consecutive weeks of acceptance and commitment therapy
participants will then receive ACT-based individual therapy weekly for twelve weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scrupulosity Obsessions and Compulsions Scale
Time Frame: At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
The Scrupulosity Obsessions and Compulsions Scale (SOCS) is a 10-item scale that asks participants how often they experience religious OCD obsessions and compulsions. The questions are asked on a scale ranging from 0 (Very Rarely) to 5 (Very Often).
At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
Experiential Avoidance Rating Scale
Time Frame: At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)
The Experiential Avoidance Rating Scale (EARS) is a 6-item scale that asks participants how true statements about avoiding experiences are for them. The questions are asked on a scale ranging from 1 (Never True) to 5 (Very Often True).
At baseline, 4 weeks, 8 weeks, and post-intervention (12 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Centrality of Religiosity Scale - Interreligious 20
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Centrality of Religiosity Scale - Interreligious 20 (CRSi-20) is a 20-item scale assessing religiosity across 5 dimensions (Intellect, Ideology, Public practice, Private practice, Experience). The questions are asked on scales ranging from Never to Several times a day, Never to Very often, and Not at all to Very much so.
Pre and post intervention which in general lasts 12 weeks
Yale-Brown Obsessive and Compulsive Scale - Self Report
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Yale-Brown Obsessive and Compulsive Scale (Y-BOCS) is a 12-item scale that asks participants whether they experience various OCD obsessions and compulsions. Participants are then asked how much time is spent on these obsessions and compulsions, whether they give in to the urge to perform compulsions, how strong the drive is to give in to compulsions, how they would feel if they were prevented from engaging in compulsions, and how much the compulsions and avoidance of compulsions interfere with their functioning.
Pre and post intervention which in general lasts 12 weeks
Patient Health Questionnaire - 9
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Patient Health Questionnaire (PHQ-9) is a 9-item scale that asks participants how often they have been bothered by aspects of depressive symptoms. The questions are asked on a scale ranging from 0 (Not at all) to 5 (Nearly every day).
Pre and post intervention which in general lasts 12 weeks
Generalized Anxiety Disorder - 7
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Generalized Anxiety Disorder Scale (GAD-7) is a 7-item scale that asks participants how often they have been bothered by statements capturing aspects of anxiety. The questions are asked on a scale ranging from 0 (Not at all) to 3 (Nearly every day).
Pre and post intervention which in general lasts 12 weeks
The Intrinsic Spirituality Scale
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Intrinsic Spirituality Scale is a 6-item scale that asks participants about aspects of their spirituality.
Pre and post intervention which in general lasts 12 weeks
Psy-Flex
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Psyflex questionnaire is a 6-item scale that measures aspects of psychological flexibility. The questions are asked on a scale ranging from very seldom to often.
Pre and post intervention which in general lasts 12 weeks
Almost Perfect Scale - Revised
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Almost Perfect Scale - Revised is a 23-item scale that asks participants their agreement on items capturing perfectionism. The questions are asked on a scale ranging from 1 (Strongly disagree) to 7 (Strongly agree).
Pre and post intervention which in general lasts 12 weeks
The Alcohol Use Disorders Identification Test
Time Frame: Pre and post intervention which in general lasts 12 weeks
The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item scale that asks participants about their alcohol consumption.
Pre and post intervention which in general lasts 12 weeks
National Institute on Drug Abuse Screener
Time Frame: Pre and post intervention which in general lasts 12 weeks
National Institute on Drug Abuse Screener (NIDA) is a 1-item scale that asks participants how often they use a variety of substances. The questions are asked on a scale ranging from Never to Daily or Almost Daily.
Pre and post intervention which in general lasts 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

October 16, 2024

First Submitted That Met QC Criteria

October 16, 2024

First Posted (Actual)

October 18, 2024

Study Record Updates

Last Update Posted (Actual)

March 19, 2026

Last Update Submitted That Met QC Criteria

March 17, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder (OCD)

Clinical Trials on Acceptance and Commitment Therapy

Subscribe